U.S., Aug. 5 -- ClinicalTrials.gov registry received information related to the study (NCT07744360) titled 'A Pilot Study Evaluating the Impact of a Prebiotic Soda on Gastrointestinal Symptoms in Users of GLP-1 Agonists' on July 29.
Brief Summary: The main objective of this study is to assess the impact of drinking a prebiotic soda on the gastrointestinal (GI) symptoms associated with the use of GLP-1 receptor agonists compared to usual fluid intake.
Study Start Date: Feb. 10
Study Type: INTERVENTIONAL
Condition:
GI Symptoms
Intervention:
OTHER: Prebiotic Soda
Participants will be randomized to consume at least one serving (12 fl oz) of prebiotic soda (6 g dietary fiber/serving) per day, with the option to consume up to two servings...